Latest news from NeuroVision on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/neurovision-imaging-inc-announces-additional-funding-from-the-addf-to-accelerate-development-of-novel-blood-based-lab-test-to-predict-dementia-before-clinical-onset/?sc=rsin /articles/neurovision-imaging-inc-announces-additional-funding-from-the-addf-to-accelerate-development-of-novel-blood-based-lab-test-to-predict-dementia-before-clinical-onset/?sc=rsin Wed, 25 Aug 2021 16:50:10 EST NeuroVision Imaging Inc. has received an additional investment from the Alzheimer's Drug Discovery Foundation to hasten development of a novel blood-based lab test to provide detection and measurement of biomarkers for Alzheimer's disease and other dementias before clinical onset. NeuroVision /articles/neurovision-imaging-inc-announces-new-funding-from-the-addf-to-develop-affordable-accessible-biomarkers-to-diagnose-alzheimer-s-and-related-dementias/?sc=rsin /articles/neurovision-imaging-inc-announces-new-funding-from-the-addf-to-develop-affordable-accessible-biomarkers-to-diagnose-alzheimer-s-and-related-dementias/?sc=rsin Tue, 02 Feb 2021 17:50:30 EST NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer's Drug Discovery Foundation (ADDF) to support developing reliable, affordable biomarker tests for Alzheimer's disease and other forms of dementia and neurodegenerative disorders. NeuroVision /²¹°ù³Ù¾±³¦±ô±ð²õ/²¹±ô³ú³ó±ð¾±³¾±ð°ù’s-³Ù³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ-°ù±ð²õ±ð²¹°ù³¦³ó-±ô±ð²¹»å±ð°ù-»å°ù.-°ù´Ç²â-³Ù·É²â³¾²¹²Ô-Âá´Ç¾±²Ô²õ-²Ô±ð³Ü°ù´Ç±¹¾±²õ¾±´Ç²Ô-¾±³¾²¹²µ¾±²Ô²µ-²ú´Ç²¹°ù»å/?²õ³¦=°ù²õ¾±²Ô /²¹°ù³Ù¾±³¦±ô±ð²õ/²¹±ô³ú³ó±ð¾±³¾±ð°ù’s-³Ù³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ-°ù±ð²õ±ð²¹°ù³¦³ó-±ô±ð²¹»å±ð°ù-»å°ù.-°ù´Ç²â-³Ù·É²â³¾²¹²Ô-Âá´Ç¾±²Ô²õ-²Ô±ð³Ü°ù´Ç±¹¾±²õ¾±´Ç²Ô-¾±³¾²¹²µ¾±²Ô²µ-²ú´Ç²¹°ù»å/?²õ³¦=°ù²õ¾±²Ô Wed, 18 Jul 2018 12:00:16 EST Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years' experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Inc. Board of Directors on July 20. NeuroVision /articles/neurovision-announces-a-15-million-series-c-financing-with-a-first-close-of-11.2-million-/?sc=rsin /articles/neurovision-announces-a-15-million-series-c-financing-with-a-first-close-of-11.2-million-/?sc=rsin Wed, 02 May 2018 06:00:01 EST NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million. The round is led by Wildcat Capital Management with funding from several new investment groups. The financing provides support for NeuroVision as it seeks validation and regulatory approval for its breakthrough, low-cost, noninvasive, eye imaging system for measuring retinal autofluorescence that can detect amyloid beta (Aβ) plaque in the eye. NeuroVision